These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35489971)

  • 1. Update on Chronic Prurigo.
    Docampo-Simón A; Sánchez-Pujol MJ; Silvestre-Salvador JF
    Actas Dermosifiliogr; 2022 Jun; 113(6):563-574. PubMed ID: 35489971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prurigo nodularis: its association with dermatoses and systemic disorders].
    Mettang T; Vonend A; Raap U
    Hautarzt; 2014 Aug; 65(8):697-703. PubMed ID: 25113328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical review of dupilumab for adult patients with prurigo nodularis.
    Biazus Soares G; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic prurigo.
    Misery L
    Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
    Vaidya DC; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
    Tanis R; Ferenczi K; Payette M
    J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
    Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
    Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus.
    Elmariah S; Kim B; Berger T; Chisolm S; Kwatra SG; Mollanazar N; Yosipovitch G
    J Am Acad Dermatol; 2021 Mar; 84(3):747-760. PubMed ID: 32682025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment.
    Gründel S; Pereira MP; Storck M; Osada N; Schneider G; Ständer S; Zeidler C
    Acta Derm Venereol; 2020 Sep; 100(16):adv00269. PubMed ID: 32556359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and prurigo nodularis in nephrogenic pruritus].
    Böhme T; Heitkemper T; Mettang T; Phan NQ; Ständer S
    Hautarzt; 2014 Aug; 65(8):714-20. PubMed ID: 25113331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
    Husein-ElAhmed H; Steinhoff M
    J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tacrolimus treatment of pruritus in prurigo nodularis.
    Halvorsen JA; Aasebø W
    Acta Derm Venereol; 2015 Sep; 95(7):866-7. PubMed ID: 25804254
    [No Abstract]   [Full Text] [Related]  

  • 13. Prurigo nodularis: Pathogenesis and management.
    Williams KA; Huang AH; Belzberg M; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
    Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
    Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
    [No Abstract]   [Full Text] [Related]  

  • 15. [THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
    Murakami Y; Sugiyama A; Ideguchi H; Murakami Y; Amimoto Y; Nishie H; Odajima H
    Arerugi; 2020; 69(3):213-217. PubMed ID: 32435023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prurigo Simplex or "Itchy Red Bump" Disease: Review and Case Series.
    Wallengren J
    Acta Derm Venereol; 2021 Sep; 101(9):adv00539. PubMed ID: 34436622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and treatment algorithm for chronic nodular prurigo.
    Ständer HF; Elmariah S; Zeidler C; Spellman M; Ständer S
    J Am Acad Dermatol; 2020 Feb; 82(2):460-468. PubMed ID: 31310842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Nodular Prurigo: A Retrospective Study of 74 Cases.
    Espiñeira Sicre J; Docampo Simón A; Silvestre Salvador JF
    Actas Dermosifiliogr; 2022 Oct; 113(9):866-873. PubMed ID: 35659612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
    Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
    N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prurigo nodularis: A puzzle for more than 100 years].
    Ständer S; Mettang T
    Hautarzt; 2014 Aug; 65(8):672-3. PubMed ID: 25113324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.